A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 108.00
GOOG 559.08
MSFT 46.95
BAC 17.16
FB 74.99

Recently Added

R 88.47
SKX 54.75
CTRE 15.53
BBRY 10.50
CMRE 20.57

Gaining Speed

CTRE 15.53
R 88.47
SKX 54.75
PNRA 161.64
CAR 55.75

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!